Loading…

S134: FLAG‐IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL

Saved in:

Bibliographic Details
Published in:	HemaSphere 2023-08, Vol.7 (S3), p.e252478c-n/a
Main Authors:	Russell, Nigel, Othman, Jad, Dillon, Richard, Potter, Nicola, Wilhelm‐Benartzi, Charlotte, Knapper, Steven, Batten, Leona, Canham, Joanna, Hinson, Emily Laura, Malthe Overgaard, Ulrik, Gilkes, Amanda, Mehta, Priyanka, Kottaridis, Panagiotis, Cavenagh, Jamie, Hemmaway, Claire, Arnold, Claire, Freeman, Sylvie, Dennis, Mike
Format:	Article
Language:	English
Subjects:	Oral Sessions
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!